Moderna, Pfizer Say They’re Close to COVID-19 Vaccine, But Huge Problems Remain It's still unclear when the FDA will greenlight the first vaccine in the U.S. By Sissi Cao
How Moderna’s Top Doctor Profited $50 Million During COVID-19 Vaccine Race Chief medical officer has been unloading 10,000 Moderna shares every week since February. By Sissi Cao
Genesis Belanger’s Classically Inspired Public Art Is a Commentary on Modern-Day Unease By Elisa Carollo
MoN Takanawa: The Museum of Narratives Is Experientially Compelling But Curatorially Thin By Elisa Carollo